Past and advances in allergen immunotherapy;Immunothérapie spécifique: Acquis et avenir

Archives de Pediatrie

Volumn 11, Issue SUPPL. II, 2004, Pages

  Just, J ^a   Goudard, E ^a   Grimfeld, A ^a  

^a AP HP 26 Ave Docteur Arnold N   (France)

Author keywords

Allergie respiratoire; Allergy; Asthma; Asthme; Child; Hypersensitivity respiratory; Immunoth erapie specifique; Imunotherapy active; Rhinite; Rhinitis

Indexed keywords

ALLERGEN; DNA VACCINE;

ALLERGIC ASTHMA; ALLERGIC CONJUNCTIVITIS; ALLERGIC DISEASE; ALLERGIC RHINITIS; CELLULAR IMMUNITY; CHILD; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DERMATOPHAGOIDES; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; POLLEN; POLLEN ALLERGY; PROVOCATION TEST; REVIEW; RHINOCONJUNCTIVITIS; RISK FACTOR; SENSITIZATION; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADMINISTRATION, SUBLINGUAL; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; INJECTIONS, SUBCUTANEOUS; RHINITIS; VACCINES, DNA;

EID: 4043146478     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Magnan A., Vervloet D. Allergies: déterminants de la polarisation Th2 et mécanismes de la désensibilisation. Rev Mal Respir. 14:1997;173-181
2. Bousquet J., Lockey R., Malling H.J. WHO position paper. Allergen immunotherapy : therapeutic vaccines for allergic diseases. Allergy. 102:1998;558-562
3. Durham S.R., Till S.J. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol. 102:1998;157-164
4. Malting H.J. Immunotherapy as an effective tool in allergy treatment. Eur J Allergy. 53:1998;461-472
5. Abramson M.J., Puy R.M., Weiner J.M. Is allergen immunotherapy effective in asthma ? A metanalysis of randomized controlled trials. Am J Respir Crit Care Med. 151:1995;969-974
6. Durham S.R., Walker S.M., Varga E.M., Jacobson M.R., O'Brien O., Noble W., et al. Long term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 341:1999;468-475
7. Moller C., Dreborg S., Lanner A., Bjorksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. Allergy. 41:1986;271-279
8. Mosbech H., Dreborg S., Madsen F., Ohlsson H., Stahl Skov P., Taudorf E., et al. High dose grass pollen tablets used for hyposensitization in hay fever patients : a one year double-blind placebo controlled study. Allergy. 42:1987;451-455
9. Giovane A., Bardare M., Passalacqua G., Ruffoni S., Scordamaglia A., Ghezzi E., et al. A three-year double blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides : evidence of safety and efficacy in pediatric patients. Clin Exp Allergy. 24:1994;53-59
10. Crimi E., Voltolini S., Troise C., Gianiorio P., Crimi P., Brusasco V., et al. Local immunotherapy with Dermatophagoides extract in asthma. J Allergy Clin Immunol. 87:1991;721-728
11. Tari M.G., Mancino M., Monti G. Immunotherapy by inhalation of allergen in powder in house-dust allergic asthma : a double blind study. J Investig Allergol Clin Immunol. 2:1992;59-67
12. Andri L., Senna G., Betteli C., Givanni S., Andri G., Dimitri G., et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis : a double-blind study. J Allergy Clin Immunol. 97:1996;34-41
13. Pocobelli D., Del Bono A., Venuti L., Falagiani P., Venuti A. Nasal immunotherapy at constant dosage : a double blind placebo controlled study in grass allergic rhinoconjunctivitis. J Investig Allergol Clin Immunol. 11:2001;79-88
14. Marcucci F., Sensi L.G., Caffarelli C., Cavagni G., Bernardini R., Tiri A., et al. Low-dose local nasal immunotherapy in children with perennial allergic rhinitis due to Dermatophagoides. Allergy. 57:2002;23-28
15. Malling H.J., Abreu-Nogueira J., Alvarez-Cuesta E., Bjorksten B., Bousquet J., Caillot D., et al. Local immunotherapy. Allergy. 53:1998;933-944
16. Morris D.L. WHO position paper on oral (sublingual) immunotherapy. Ann Allergy Asthma Immunol. 83:1999;423-424
17. Pajno G.B., Morabito L., Barberio G., Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitised to mites : a double-blind, placebo-controlled study. Allergy. 55:2000;842-849
18. Bousquet J., Scheinmann P., Guinnepin M.T., Perrin-Fayolle M., Sauvaget J., Tonnel A.B., et al. Sublingual-swallow immunotherapy in patients with asthma due to house-dust mite : a double-blind, placebo-controlled study. Allergy. 54:1999;249-260
19. Bahceciler N.N., Isik U., Barlan I.B. Efficacy of sublingual immunotherapy in children with asthma and rhinitis : a double-blind, placebo-controlled study. Pediatr Pulmonol. 32:2001;49-55
20. Di Rienzo V., Pagani A., Parmiani S. Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients. Allergy. 54:1999;1110-1113
21. André C., Vatrinet C., Galvain S., Carat F., Sicart H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol. 121:2000;229-234
22. Bousquet J., Van Cauwenberge P., Khaltaev N. Allergic rhinitis and its impact on asthma. ARIA. WHO initiative. J Allergy Clin Immunol. 108:2001;S147-S334
23. Mungan D., Misirligil Z., Gurbuz L. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma : a placebo-controlled shady. Ann Allergy Asthma Immunol. 82:1999;485-490
24. Ongari S., Domeneghetti P., Parniani S. Comparison among drugs, injective IT and sublingual IT in grass allergic patients. Allergy. 50:1995;358
25. Platts-Mills T.A., Mueller G.A., Wheatley L.M. Future directions for allergen immunotherapy. J Allergy Clin Immunol. 102:1998;335-343
26. Oldfield W.L., Kay A.B., Larché M. Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen specific hyporesponsiveness in atopic allergic asthmatic subjects. J Immunol. 167:2001;1734-1749
27. Horner A.A., Takabaysahi K., Zubeldia J.M., Raz E. Immunostimulatory DNA-based therapeutics for experimental and clinical allergy. Allergy. 57:2002;24-29
28. Moller C., Dreborg S., Ferdousi H.A., Halken S., Host A., Jacobsen L., et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 109:2002;251-256
29. Di Rienzo V., marcucci F., Puccinelli P., Parmiani S., Frati F., Sensi L., et al. Long lasting effect of sublingual immunotherapy in children with asthma due to house-dust mites : a ten-year prospective study. Clin Exp Allergy. 33:2003;206-210
30. Des Roches A., Paradis L., Menardo J.L., Bouges S., Daures J.P., Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents onset of new sensitizations in children. J Allergy Clin Immunol. 99:1997;450-453
31. Pajno G.B., Barberio G., De Luca F. Prevention of new sensitizations in asthmatic children monosensitized to house-dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 31:2001;1392-1397
32. Purello-D'Ambrosio F., Gangemi S., Merendino R.A. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy. 31:2001;1295-1302
33. Eng P.A., Reinhold M., Gnehm H.P. Long-term efficacy of preseaonal grass pollen immunotherapy in children. Allergy. 57:2002;306-312
34. Kuehr J., Brauburger J., Zielen S., Schauer U., Kamin W., Von Berg A., et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol. 109:2002;274-280